Dimensional Fund Advisors LP Pds Biotechnology Corp Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 18,382 shares of PDSB stock, worth $17,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,382
Previous 18,382
-0.0%
Holding current value
$17,462
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PDSB
# of Institutions
60Shares Held
7.71MCall Options Held
98.2KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$2.12 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.85 Million0.0% of portfolio
-
Ubs Group Ag543KShares$515,8690.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$462,6180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$397,0370.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $27M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...